Kore Private Wealth LLC Astrazeneca PLC Transaction History

Kore Private Wealth LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $9,129 - $10,787	-169 Reduced 3.33%	4,910 $286,000
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $282,189 - $308,752	5,079 New	5,079 $305,000
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $36,671 - $42,220	-691 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $1,120 - $1,438	-26 Reduced 3.63%	691 $36,000
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $8,767 - $11,908	232 Added 47.84%	717 $32,000
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $20,593 - $24,473	485 New	485 $24,000
Q1 2019 May 16, 2019	SELL	$35.49 - $43.02 $1,668 - $2,021	-47 Closed	0 $0
Q4 2018 May 23, 2019	BUY	$36.86 - $41.49 $1,732 - $1,950	47 New	47 $2,000

1,358

512M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $234B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.